When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective

Authors

Keywords

Journal

Volume 86, Issue 5, Pages 475-479

Publisher

Springer Nature

Online

2009-10-21

DOI

10.1038/clpt.2009.190

References

View 5 related references

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started